Literature DB >> 35371783

Intractable Epilepsy in Maternally Inherited Leigh Syndrome (MILS) Due to the Sporadic Variant m.8993T>G in MT-ATP6: A Case Report.

Josef Finsterer1.   

Abstract

Epilepsy is a common phenotypic feature of Leigh syndrome. However, data about the characteristics, treatments, and outcomes of epilepsy in maternally inherited Leigh syndrome (MILS) are limited. A four-year-old boy with sporadic MILS developed epilepsy at the age of five months. His condition was diagnosed at birth and was caused by the m.8993T>G variant with a heteroplasmy rate of 90% in skin fibroblasts. The patient presented with absences, and focal and generalized tonic-clonic seizures. Despite treatment with anti-seizure drugs such as vigabatrin, lamotrigine, clonazepam, diazepam, clobazam, and phenobarbital, seizure control was insufficient, and seizures became intractable. The patient died after recurrent aspiration, pneumonia, and sepsis. In conclusion, the m.8993T>G variant can occur sporadically, and m.8993T>G carriers with MILS may develop epilepsy as the disease progresses. Moreover, the treatment for epilepsy in MILS can be challenging, and epilepsy can become intractable and can contribute to fatal outcomes.
Copyright © 2022, Finsterer et al.

Entities:  

Keywords:  genetics; leigh syndrome; mitochondrial disorder; mtdna; respiratory chain

Year:  2022        PMID: 35371783      PMCID: PMC8971112          DOI: 10.7759/cureus.22716

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation.

Authors:  J M Shoffner; P M Fernhoff; N S Krawiecki; D B Caplan; P J Holt; D A Koontz; Y Takei; N J Newman; R G Ortiz; M Polak
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

2.  Significance of rostral brain lesions of Leigh syndrome associated with the mitochondrial DNA 8993T > G mutation.

Authors:  Yukiko Iida; Katsunori Fujii
Journal:  J Neurol Sci       Date:  2016-05-12       Impact factor: 3.181

3.  Mitochondrial gene therapy improves respiration, biogenesis, and transcription in G11778A Leber's hereditary optic neuropathy and T8993G Leigh's syndrome cells.

Authors:  Shilpa Iyer; Kristen Bergquist; Kisha Young; Erich Gnaiger; Raj R Rao; James P Bennett
Journal:  Hum Gene Ther       Date:  2012-04-17       Impact factor: 5.695

4.  A T-to-G mutation at nucleotide pair 8993 in mitochondrial DNA in a patient with Leigh's syndrome.

Authors:  H Yoshinaga; T Ogino; S Ohtahara; R Sakuta; I Nonaka; S Horai
Journal:  J Child Neurol       Date:  1993-04       Impact factor: 1.987

5.  High mitochondrial DNA T8993G mutation (<90%) without typical features of Leigh's and NARP syndromes.

Authors:  C Y Tsao; J R Mendell; D Bartholomew
Journal:  J Child Neurol       Date:  2001-07       Impact factor: 1.987

6.  Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation.

Authors:  I Desguerre; F Pinton; R Nabbout; M L Moutard; S N'Guyen; C Marsac; G Ponsot; O Dulac
Journal:  Neuropediatrics       Date:  2003-06       Impact factor: 1.947

7.  Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome.

Authors:  Martine Uittenbogaard; Christine A Brantner; ZiShui Fang; Lee-Jun C Wong; Andrea Gropman; Anne Chiaramello
Journal:  Mol Genet Metab       Date:  2018-03-27       Impact factor: 4.797

8.  Genotype-phenotype analysis of MT-ATP6-associated Leigh syndrome.

Authors:  Ji-Hoon Na; Young-Mock Lee
Journal:  Acta Neurol Scand       Date:  2021-12-07       Impact factor: 3.209

9.  Epilepsy in MT-ATP6 - related mils/NARP: correlation of elettroclinical features with heteroplasmy.

Authors:  Laura Licchetta; Lorenzo Ferri; Chiara La Morgia; Corrado Zenesini; Leonardo Caporali; Maria Lucia Valentino; Raffaella Minardi; Daniela Fulitano; Lidia Di Vito; Barbara Mostacci; Lara Alvisi; Patrizia Avoni; Rocco Liguori; Paolo Tinuper; Francesca Bisulli; Valerio Carelli
Journal:  Ann Clin Transl Neurol       Date:  2021-01-21       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.